Search by Drug Name or NDC

    NDC 68462-0266-23 atomoxetine 18 mg/1 Details

    atomoxetine 18 mg/1

    atomoxetine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., USA. The primary component is ATOMOXETINE HYDROCHLORIDE.

    Product Information

    NDC 68462-0266
    Product ID 68462-266_84dc1413-a85b-41f6-a3e3-6e76c01f6803
    Associated GPIs 61354015100118
    GCN Sequence Number 051490
    GCN Sequence Number Description atomoxetine HCl CAPSULE 18 MG ORAL
    HIC3 H7Y
    HIC3 Description TX FOR ATTENTION DEFICIT-HYPERACT.(ADHD), NRI-TYPE
    GCN 18777
    HICL Sequence Number 024703
    HICL Sequence Number Description ATOMOXETINE HCL
    Brand/Generic Generic
    Proprietary Name atomoxetine
    Proprietary Name Suffix n/a
    Non-Proprietary Name atomoxetine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 18
    Active Ingredient Units mg/1
    Substance Name ATOMOXETINE HYDROCHLORIDE
    Labeler Name Glenmark Pharmaceuticals Inc., USA
    Pharmaceutical Class Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA079019
    Listing Certified Through 2024-12-31

    Package

    NDC 68462-0266-23 (68462026623)

    NDC Package Code 68462-266-23
    Billing NDC 68462026623
    Package 2000 CAPSULE in 1 BOTTLE (68462-266-23)
    Marketing Start Date 2017-05-30
    NDC Exclude Flag N
    Pricing Information N/A